|
Market Closed -
Bombay S.E.
06:02:23 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 427.30 INR | -1.01% |
|
+3.98% | +3.75% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Announces Management Changes | CI |
| Market Cap | 39B 409M 354M 332M 303M 569M 578M 3.9B 1.53B 19.53B 1.54B 1.5B 65.11B | P/E 2026 |
15x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 39B 409M 354M 332M 303M 569M 578M 3.9B 1.53B 19.53B 1.54B 1.5B 65.11B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.32x |
| Free-Float |
40.44% | Yield 2026 * |
0.93% | Yield 2027 * | 1.37% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -1.01% | ||
| 1 week | +3.98% | ||
| Current month | +0.90% | ||
| 1 month | +8.15% | ||
| 3 months | +16.43% | ||
| 6 months | +15.11% | ||
| Current year | +3.75% |
| 1 week | 408.95 |  | 453.2 |
| 1 month | 396.2 | | 453.2 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 534.15 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 648 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +3.98% | -12.47% | -23.97% | 413M | |
| +0.17% | +4.31% | +90.84% | +130.99% | 1,088B | |
| +0.04% | +1.87% | +50.09% | +50.94% | 629B | |
| +1.63% | +3.81% | +25.65% | +66.25% | 440B | |
| -0.79% | +0.05% | +46.14% | +37.78% | 359B | |
| -0.37% | -0.89% | +27.21% | +36.45% | 291B | |
| -0.58% | -1.49% | +1.84% | +4.86% | 245B | |
| +0.39% | +2.85% | +43.92% | +59.56% | 225B | |
| -0.73% | +1.43% | -8.62% | -51.91% | 204B | |
| +0.68% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | -0.08% | +1.75% | +27.78% | +38.08% | 364.96B | |
| Weighted average by Cap. | +0.10% | +1.93% | +48.46% | +66.73% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 273M 237M 222M 202M 380M 386M 2.61B 1.02B 13.05B 1.03B 1B 43.52B | 29.45B 309M 268M 251M 229M 430M 436M 2.95B 1.15B 14.75B 1.16B 1.13B 49.18B |
| Net income | 1.82B 19.1M 16.55M 15.51M 14.14M 26.59M 27M 182M 71.29M 912M 71.72M 70.16M 3.04B | 2.15B 22.56M 19.55M 18.32M 16.71M 31.41M 31.89M 215M 84.21M 1.08B 84.71M 82.87M 3.59B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | ₹427.30 | -1.01% | 8,818 |
| 26-08-12 | ₹431.65 | -1.81% | 26,434 |
| 26-08-11 | ₹439.60 | +4.33% | 62,538 |
| 26-08-10 | ₹421.35 | +1.20% | 10,224 |
| 26-08-07 | ₹416.35 | +1.31% | 4,334 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
